TY - JOUR
T1 - A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies
AU - Kulkarni, Jayashri
AU - Worsley, Roisin
AU - Gilbert, Heather Alison
AU - Gavrilidis, Emorfia
AU - Van Rheenen, Tamsyn
AU - Wang, Wei Chun
AU - McCauley, Kay Madelon
AU - Fitzgerald, Paul Bernard
PY - 2014
Y1 - 2014
N2 - Background: Many women diagnosed with varying psychiatric disorders take antipsychotic medications during pregnancy. The safety of antipsychotic medications in pregnancy is largely unknown. Methods: We established the National Register of Antipsychotic Medications in Pregnancy in 2005. Women who are pregnant and taking an antipsychotic medication are interviewed every 6 weeks during pregnancy and then followed until their babies are one year old. The baby s progress is closely followed for the first year of life. Findings: As of April 18 2012, 147 pregnancies had been followed through to completion. There were 142 live births and data is available for 100 one year old babies. 18 of babies were born preterm, with a higher dose of antipsychotic medication correlating to an increased likelihood of premature delivery; 43 of babies required special care nursery or intensive care after birth; 37 had any degree of respiratory distress and 15 of babies developed withdrawal symptoms. Congenital anomalies were seen in eight babies. Most pregnancies resulted in the birth of live, healthy babies. The use of mood stabilisers or higher doses of antipsychotics during pregnancy increased the likelihood of babies experiencing respiratory distress or admission to Special Care Nursery or Neonatal Intensive Care Units. Conclusion: There is a great need for safety and efficacy information about the use of antipsychotic medications in pregnancy. Live, healthy babies are the most common outcome following the use of antipsychotic medication in pregnancy, but clinicians should be particularly mindful of neonatal problems such as respiratory distress. ? 2014 Kulkarni et al.
AB - Background: Many women diagnosed with varying psychiatric disorders take antipsychotic medications during pregnancy. The safety of antipsychotic medications in pregnancy is largely unknown. Methods: We established the National Register of Antipsychotic Medications in Pregnancy in 2005. Women who are pregnant and taking an antipsychotic medication are interviewed every 6 weeks during pregnancy and then followed until their babies are one year old. The baby s progress is closely followed for the first year of life. Findings: As of April 18 2012, 147 pregnancies had been followed through to completion. There were 142 live births and data is available for 100 one year old babies. 18 of babies were born preterm, with a higher dose of antipsychotic medication correlating to an increased likelihood of premature delivery; 43 of babies required special care nursery or intensive care after birth; 37 had any degree of respiratory distress and 15 of babies developed withdrawal symptoms. Congenital anomalies were seen in eight babies. Most pregnancies resulted in the birth of live, healthy babies. The use of mood stabilisers or higher doses of antipsychotics during pregnancy increased the likelihood of babies experiencing respiratory distress or admission to Special Care Nursery or Neonatal Intensive Care Units. Conclusion: There is a great need for safety and efficacy information about the use of antipsychotic medications in pregnancy. Live, healthy babies are the most common outcome following the use of antipsychotic medication in pregnancy, but clinicians should be particularly mindful of neonatal problems such as respiratory distress. ? 2014 Kulkarni et al.
UR - http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0094788&representation=PDF
U2 - 10.1371/journal.pone.0094788
DO - 10.1371/journal.pone.0094788
M3 - Article
SN - 1932-6203
VL - 9
JO - PLoS ONE
JF - PLoS ONE
IS - 5
M1 - e94788
ER -